LA reports being a consultant to Analgesic Solutions, Aptinyx, Axsome Therapeutics, Eliem Therapeutics, Ono Pharmaceuticals, and Scilex; and receiving grants from AbbVie, Aptinyx, Otsuka, Swing Therapeutics (principal investigator for the clinical investigation presented in the discussed Correspondence), Teva Pharmaceuticals, Tonix Pharmaceuticals, and Virios Therapeutics. RMG reports being a consultant and receiving stock options from Swing Therapeutics as well as being a consultant to Tonix Pharmaceuticals. LMM reports being a consultant to Swing Therapeutics. BV reports having consulted for Swing Therapeutics. MJR reports being a founder and chief executive officer of, and receiving stock options and salary from, Swing Therapeutics.